Looks like this event has already ended.
Check out upcoming events by this organizer, or organize your very own event.
SoCalBio Women, Work & Wisdom (W3) Group Meeting in Orange County: Building & Nurturing Successful Bioscience Companies in Southern California
Thursday, May 10, 2012 from 4:00 PM to 7:00 PM (PDT)
Offered in Partnership with California Institute for Telecommunications and Information and the Office of the Vice Chancellor for Research at the University of California Irvine
(No Refund. Substitutions Accepted)
This is a mixer for bioscience women executives and allied service providers affiliated with SoCalBio to encourage networking and mutual support among bioscience women executives and company managers in Southern California.
Event features a presentation by the following renowned bioscience entrepreneurs who will share their life stories in building and nurturing bioscience companies in Southern California:
France Dixon Helfer
President & CEO
Halo Healthcare - Neomatrix
Sharon Stevenson, DVM, PHD
Okapi Venture Capital
Sharon is a Co-Founder and Managing Director of Okapi Venture Capital and focuses on Okapi Ventures' life science investments. Sharon was responsible for Okapi’s investment in Helixis (acq: ILMN), and serves as a Director on the boards of Okapi portfolio companies OrthAlign, Obalon Therapeutics, PathCentral, and WellTok. Prior to founding Okapi, Sharon was the Senior Vice President of Technology and Planning for SkinMedica- a private, venture-backed, commercial stage specialty pharmaceutical company focused on the dermatology and human appearance markets. Prior to SkinMedica, Sharon was a Principal with Domain Associates, LLC - a venture capital fund specializing in life science investments. In addition to performing due diligence and working closely with portfolio companies while at Domain, she also served as President and CFO of Volcano Therapeutics (Nasdaq: VOLC) and lead the company's growth from 1 to 14 employees and from the initial design of the first product to the first clinical trials using the device.
4:00 Registration & cocktail reception
7:00 Meeting adjourns